3 tracked superinvestors hold Regeneron Pharmaceuticals, Inc. (REGN), worth $2.9B combined, led by Team. Smart money is accumulating REGN as of the latest 13F filings.
Current price
$667.95
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macular edema following retinal vein occlusion, including…
Market cap
$72.3B
P/E
17.12
Div yield
0.6%
Revenue YoY
1.0%
Analyst target
$836
Snapshot for context. For deep analysis use a stock screener — this page is about who owns it.
Superinvestors holding
3
tracked 13F / N-PORT funds
Combined value
$2.9B
disclosed long exposure
Tier-1 conviction
0
concentrated holders
Net this quarter
+1
1 buying · 0 selling
Smart money is net accumulating REGN: 1 funds added or opened versus 0 trimming.
Regeneron Pharmaceuticals, Inc. (REGN) appears mainly in diversified and quant books here (3 funds, $2.9B combined) rather than in concentrated conviction portfolios — read the holders below with that in mind.
The largest position belongs to Team at 2% of their book — no single tracked manager treats it as an outsized, top-weighted bet.
No tracked fund opened a new position this quarter; 1 added and 0 trimmed, a net add.
| Investor | Move | % of their portfolio | Position value |
|---|---|---|---|
| Held | 2% | $2.2B | |
| Added | 0.5% | $628M | |
| Held | 0.2% | $64M |
Tier badge = signal quality: 1 concentrated conviction · 2 quant/multi (context) · 3 retail & diversified. Only Tier 1 holdings feed the consensus signal.
Which superinvestors own REGN?
3 tracked funds hold Regeneron Pharmaceuticals, Inc. (REGN), the largest being Team (Dodge & Cox Stock) at 2% of its 13F portfolio. 0 of them are concentrated Tier-1 conviction managers.
Is smart money buying or selling REGN?
In the most recent 13F quarter, 1 tracked fund added or opened REGN and 0 trimmed it.
How much REGN do tracked funds hold?
Combined disclosed long exposure to REGN across tracked superinvestors is $2.9B as of the Mar 2026 filings.
Holdings aggregated from the latest SEC 13F & N-PORT filings via FMP · Mar 2026 quarter. Long equity positions only, reported with up to a 45-day delay — for activity between filings see real-time moves. Not financial advice.